Maze Therapeutics names Paula Johnson, Sophie Kornowski to board of directors

Reuters2026/08/17 20:18

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Maze Therapeutics named Paula Johnson and Sophie Kornowski to its board of directors.
Johnson is president of Wellesley College; she previously led the Connors Center at Brigham and Women’s Hospital.
Kornowski was CEO of Boston Pharmaceuticals from 2022; she previously led partnering at Roche and served on Chugai’s board.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-354092), on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Maze Therapeutics names Paula Johnson, Sophie Kornowski to board of directors

You may also like

Crypto prices